Interleukin-22 Attenuates Acute Pancreatitis-Associated Intestinal Mucosa Injury in Mice via STAT3 Activation
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Interleukin-22 (IL-22) is an important cytokine maintaining homeostasis at barrier surfaces. In this study, the role of IL-22 in acute pancreatitis-associated intestinal injury was further explored. Methods: Severe acute pancreatitis (SAP) was induced by administration of L-arginine in Balb/c mice at different time gradients. Histopathological examinations were made in both the pancreas and small intestine. Furthermore, recombinant murine IL-22 (rIL-22) was administrated to L-arginine-induced SAP mice by intraperitoneal injection. The mRNA levels of IL-22R1, Reg-IIIβ, Reg-IIIγ, Bcl-2, and Bcl-xL were detected in the small intestine by real-time polymerase chain reaction, and protein levels of total and phosphorylated STAT3 were assessed via Western blot. Results: Compared with normal control group, 72 hours of L-arginine exposure induced the most characteristic histopathological changes of SAP, evidenced by pathological changes and serum amylase levels. Meanwhile, significant pancreatitis-associated intestinal mucosa injury was also observed. The gene expression levels of antimicrobial proteins Reg-IIIβ, Reg-IIIγ and anti-apoptosis proteins Bcl-2, Bcl-xL were downregulated in small intestine. Furthermore, Larginine- induced SAP was attenuated by rIL-22 treatment. Importantly, pancreatitis-associated intestinal mucosa injury was also ameliorated, reflected by improved pathological changes and significant increase in gene expression levels of Reg-IIIβ, Reg-IIIγ, Bcl-2 and Bcl-xL. Consistently, serum amylase levels and mortality were decreased in mice treated with rIL-22. Mechanistically, the upregulated expressions of these protective genes were achieved by activating STAT3. Conclusions: Exogenous rIL-22 attenuates L-arginine-induced acute pancreatitis and intestinal mucosa injury in mice, via activating STAT3 signaling pathway and enhancing the expression of antimicrobial peptides and antiapoptotic genes.
Abstract
Background/Aims: Interleukin-22 (IL-22) is an important cytokine maintaining homeostasis at barrier surfaces. In this study, the role of IL-22 in acute pancreatitis-associated intestinal injury was further explored. Methods: Severe acute pancreatitis (SAP) was induced by administration of L-arginine in Balb/c mice at different time gradients. Histopathological examinations were made in both the pancreas and small intestine. Furthermore, recombinant murine IL-22 (rIL-22) was administrated to L-arginine-induced SAP mice by intraperitoneal injection. The mRNA levels of IL-22R1, Reg-IIIβ, Reg-IIIγ, Bcl-2, and Bcl-xL were detected in the small intestine by real-time polymerase chain reaction, and protein levels of total and phosphorylated STAT3 were assessed via Western blot. Results: Compared with normal control group, 72 hours of L-arginine exposure induced the most characteristic histopathological changes of SAP, evidenced by pathological changes and serum amylase levels. Meanwhile, significant pancreatitis-associated intestinal mucosa injury was also observed. The gene expression levels of antimicrobial proteins Reg-IIIβ, Reg-IIIγ and anti-apoptosis proteins Bcl-2, Bcl-xL were downregulated in small intestine. Furthermore, Larginine- induced SAP was attenuated by rIL-22 treatment. Importantly, pancreatitis-associated intestinal mucosa injury was also ameliorated, reflected by improved pathological changes and significant increase in gene expression levels of Reg-IIIβ, Reg-IIIγ, Bcl-2 and Bcl-xL. Consistently, serum amylase levels and mortality were decreased in mice treated with rIL-22. Mechanistically, the upregulated expressions of these protective genes were achieved by activating STAT3. Conclusions: Exogenous rIL-22 attenuates L-arginine-induced acute pancreatitis and intestinal mucosa injury in mice, via activating STAT3 signaling pathway and enhancing the expression of antimicrobial peptides and antiapoptotic genes.
참고문헌 (47)
- Gravante G, "Prediction of mortality in acute pancreatitis: a systematic review of the published evidence", Pancreatology, 9, pp.601~614 (2009)
- Harper SJ, "Acute pancreatitis", Ann Clin Biochem, 48(Pt 1), pp.23~37 (2011)
- Petrov MS, "Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis", Gastroenterology, 139, pp.813~820 (2010)
- Yasuda T, "Breakdown of intestinal mucosa via accelerated apoptosis increases intestinal permeability in experimental severe acute pancreatitis", J Surg Res, 135, pp.18~26 (2006)
- Sun X, "Melatonin reduces bacterial translocation by preventing damage to the intestinal mucosa in an experimental severe acute pancreatitis rat model", Exp Ther Med, 6, pp.1343~1349 (2013)
- Dumoutier L, "Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor", IL-22, 2001, pp.166, 7090~7095
- Seiderer J, "IL-22: a two-headed cytokine in IBD?", Inflamm Bowel Dis, 15, pp.473~474 (2009)
- Witte E, "Interleukin-22 : a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection", Cytokine Growth Factor Rev, 21, pp.365~379 (2010)
- Ouyang W, "Regulation and functions of the IL-10 family of cytokines in inflammation and disease", Annu Rev Immunol, 29, pp.71~109 (2011)
- Sonnenberg GF, "Border patrol : regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22", Nat Immunol, 12, pp.383~390 (2011)
- Zenewicz LA, "Recent advances in IL-22 biology", Int Immunol, 23, pp.159~163 (2011)
- Wolk K, "IL-22 increases the innate immunity of tissues", Immunity, 21, pp.241~254 (2004)
- Xie MH, "Interleukin(IL)-22, a novel human cytokine that signals through the interferon receptor-related proteins CRF2-4 and IL-22R", J Biol Chem, 275, pp.31335~31339 (2000)
- Sonnenberg GF, "Innate lymphoid cells promote anatomical containment of lymphoidresident commensal bacteria", Science, 336, pp.1321~1325 (2012)
- Dawra R, "Development of a new mouse model of acute pancreatitis induced by administration of L-arginine", Am J Physiol Gastrointest Liver Physiol, 292, pp.G1009~ (2007)
- Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))Method", Methods, 25, pp.402~408 (2001)
- Velusamy RK, "Protective effect of methylsulfonylmethane in caerulein-induced acute pancreatitis and associated lung injury in mice", J Pharm Pharmacol, 70, pp.1188~1199 (2018)
- Xue J, "Aryl hydrocarbon receptor regulates pancreatic IL-22 production and protects mice from acute pancreatitis", Gastroenterology, 143, pp.1670~1680 (2012)
- Ashkenazi A, "From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors", Nat Rev Drug Discov, 16, pp.273~284 (2017)
- Glal D, "ATF3 sustains IL22-induced STAT3 phosphorylation to maintain mucosal immunity through inhibiting phosphatases", Front Immunol, 9, pp.2522~ (2018)
- Radaeva S, "Interleukin 22(IL-22)plays a protective role in T cell-mediated murine hepatitis : IL-22 is a survival factor for hepatocytes via STAT3activation", Hepatology, 39, pp.1332~1342 (2004)
- Mounzer R, "Comparison of existing clinical scoring systems to predict persistent organ failure in patients with acute pancreatitis", Gastroenterology, 142, pp.1476~1482 (2012)
- Mole DJ, "Kynurenine-3-monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis", Nat Med, 22, pp.202~209 (2016)
- Lu Y, "Protective effects of saizen in combination with stilamin on intestinal mucosa of a rabbit model of severe acute pancreatitis", Pancreas, 42, pp.102~107 (2013)
- Juvonen PO, "Gut permeability in patients with acute pancreatitis", Scand J Gastroenterol, 35, pp.1314~1318 (2000)
- Gurney AL, "IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues", Int Immunopharmacol, 4, pp.669~677 (2004)
- Zheng Y, "Interleukin-22mediates early host defense against attaching and effacing bacterial pathogens", Nat Med, 14, pp.282~289 (2008)
- Pickert G, "STAT3 links IL-22signaling in intestinal epithelial cells to mucosal wound healing", J Exp Med, 206, pp.1465~1472 (2009)
- Gallo RL, "Epithelial antimicrobial defence of the skin and intestine", Nat Rev Immunol, 12, pp.503~516 (2012)
- Cash HL, "Symbiotic bacteria direct expression of an intestinal bactericidal lectin", Science, 313, pp.1126~1130 (2006)
- Rendon JL, "Interleukin-22modulates gut epithelial and immune barrier functions following acute alcohol exposure and burn injury", Shock, 39, pp.11~18 (2013)
- Lehotzky RE, "Molecular basis for peptidoglycan recognition by a bactericidal lectin", Proc Natl Acad Sci U S A, 107, pp.7722~7727 (2010)
- Vaishnava S, "The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine", Science, 334, pp.255~258 (2011)
- Miki T, "Outer membrane permeabilization is an essential step in the killing of Gram-negative bacteria by the lectin RegIIIβ", PLoS One, 8, pp.e69901~ (2013)
- Sugimoto K, "IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis", J Clin Invest, 118, pp.534~544 (2008)
- Mylonas PG, "Growth hormone and insulin-like growth factor I protect intestinal cells from radiation induced apoptosis", Mol Cell Endocrinol, 160, pp.115~122 (2000)
- Ikeda H, "Apoptosis is a major mode of cell death caused by ischaemia and ischaemia", reperfusion injury to the rat intestinal epithelium, 1998, pp.42, 530~537
- Wang X, "Beneficial effects of growth hormone on bacterial translocation during the course of acute necrotizing pancreatitis in rats", Pancreas, 23, pp.148~156 (2001)
- Shinzeki M, "Intraperitoneal administration of oxygenated perfluorochemical inhibits bacterial translocation associated with severe acute pancreatitis", Kobe J Med Sci, 49, pp.17~24 (2003)
- Czabotar PE, "Control of apoptosis by the BCL-2 protein family : implications for physiology and therapy", Nat Rev Mol Cell Biol, 15, pp.49~63 (2014)
- Pan H, "Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3", Cell Mol Immunol, 1, pp.43~49 (2004)
- Feng D, "Interleukin-22 ameliorates cerulein-induced pancreatitis in mice by inhibiting the autophagic pathway", Int J Biol Sci, 8, pp.249~257 (2012)
- Cox JH, "Opposing consequences of IL-23 signaling mediated by innate and adaptive cells in chemically induced colitis in mice", Mucosal Immunol, 5, pp.99~109 (2012)
- Ki SH, "Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding : role of signal transducer and activator of transcription 3", Hepatology, 52, pp.1291~1300 (2010)
- Chestovich PJ, "Interleukin-22 : im-plications for liver ischemia-reperfusion injury", Transplantation, 93, pp.485~492 (2012)
- Nagalakshmi ML, "Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells", Int Immunopharmacol, 4, pp.679~691 (2004)
- Gao B, "Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease", J Gastroenterol Hepatol, 27(Suppl 2), pp.89~93 (2012)